5-Amino-1MQ (10 mg): the NNMT inhibitor that isn't a peptide 5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of NNMT
Factors such as cost savings, convenience, absorption issues, potential digestion, and comfort with self-administering injections can affect patients preferences
A 503B outsourcing facility voluntarily registers with the FDA, may compound certain products without patient-specific prescriptions, must comply with current good manufacturing practice requirements, and is subject to FDA inspection and reporting obligations
Biochimica et Biophysica Acta (BBA) General Subjects, 2013
Frequently asked questions Research-use disclaimer Information on this page is provided for educational and scientific reference purposes only
In patients with Leber's disease, administration of cyanocobalamin may cause acute and rapid atrophy of the optic nerve